Early results from the ongoing QUILT-106 clinical trial (NCT06334991) show that the treatment combination of CD19 chimeric antigen receptor natural killer (CAR-NK) cells with rituximab (Rituxan) can ...
Cases of respiratory syncytial virus are increasing, but vaccines and antibody shots can keep young children out of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback